|

PF-08634404 Clinical Trials

6 actively recruiting trials across 2 locations

Also known as: SSGJ-707

Pipeline

Phase 3: 2Phase 1/2: 3Phase 2/3: 1

Top Sponsors

  • Pfizer6

Indications

  • Cancer6
  • Lung Cancer3
  • Carcinoma, Non-Small-Cell Lung2
  • Non Small Cell Lung Cancer2
  • Metastatic/Advanced Renal Cell Carcinoma1

Springdale, Arkansas3 trials

A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Highlands Oncology Group

Phase 1/2
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Highlands Oncology Group

Phase 2/3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Highlands Oncology Group

Phase 3

Orange City, Florida2 trials

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Mid Florida Hematology and Oncology Center

Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Mid Florida Hematology and Oncology Center

Phase 1/2

Other1 trial

A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.